Literature DB >> 1959522

Osteochondrosis in the horse--searching for the key to pathogenesis.

L B Jeffcott1.   

Abstract

This paper reviews current developments in equine osteochondrosis complex and the clinical syndromes associated with it. Although the primary lesion has been defined as a failure of endochondral ossification, its definitive cause is unknown and appears to involve heredity, growth rate, nutrition, mineral imbalance, endocrinological dysfunction and biomechanical trauma. Despite the international importance of osteochondrosis in horses, surprisingly few controlled investigations have been performed on its pathogenesis. The studies that have been conducted suggest that local effects on differentiating growth cartilage are the key to a more complete understanding of the problem. Gaps in the current knowledge include in-depth understanding of the life cycle of chondrocytes in growth cartilage, the process of mineralisation and the use of a standard experimental model for the induction of osteochondrosis. The ultimate goal of osteochondrosis research must be to prevent or reduce the incidence of the condition in horses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1959522     DOI: 10.1111/j.2042-3306.1991.tb03733.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  18 in total

1.  Serum copper and ceruloplasmin activity at the early growing stage in foals.

Authors:  M Okumura; M Asano; M Tagami; K Tsukiyama; T Fujinaga
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

2.  Incidence of osteochondrosis (dissecans) in Dutch warmblood horses presented for pre-purchase examination.

Authors:  Nicolas J Vos
Journal:  Ir Vet J       Date:  2008-01-01       Impact factor: 2.146

3.  Variations of plasmatic concentrations of Insulin-like Growth Factor-I in post-pubescent horses affected with developmental osteochondral lesions.

Authors:  D R Verwilghen; L Vanderheyden; T Franck; V Busoni; E Enzerink; M Gangl; J-P Lejeune; G van Galen; S Grulke; D Serteyn
Journal:  Vet Res Commun       Date:  2009-03-25       Impact factor: 2.459

4.  Genome-wide search for markers associated with osteochondrosis in Hanoverian warmblood horses.

Authors:  Claudia Dierks; Kathrin Löhring; Virginie Lampe; Catherine Wittwer; Cord Drögemüller; Ottmar Distl
Journal:  Mamm Genome       Date:  2007-09-29       Impact factor: 2.957

Review 5.  Emerging genetic basis of osteochondritis dissecans.

Authors:  J Tyler Bates; John C Jacobs; Kevin G Shea; Julia Thom Oxford
Journal:  Clin Sports Med       Date:  2014-01-10       Impact factor: 2.182

6.  Porcine osteochondrosis: deficiencies in transforming growth factor-beta and insulin-like growth factor-I.

Authors:  B H Thorp; S Ekman; S B Jakowlew; C Goddard
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

7.  Alterations in sclerostin protein in lesions of equine osteochondrosis.

Authors:  Jonathon Power; Paula Hernandez; John Wardale; Frances M D Henson
Journal:  Vet Rec Open       Date:  2014-02-04

8.  Age-dependent expression of osteochondrosis-related genes in equine leukocytes.

Authors:  L Mendoza; D Piquemal; J P Lejeune; L Vander Heyden; F Noguier; R Bruno; C Sandersen; D Serteyn
Journal:  Vet Rec Open       Date:  2015-03-24

9.  Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis.

Authors:  Clémence Desjardin; Julie Riviere; Anne Vaiman; Caroline Morgenthaler; Mathieu Diribarne; Michel Zivy; Céline Robert; Laurence Le Moyec; Laurence Wimel; Olivier Lepage; Claire Jacques; Edmond Cribiu; Laurent Schibler
Journal:  BMC Genomics       Date:  2014-10-31       Impact factor: 3.969

10.  Next-generation sequencing identifies equine cartilage and subchondral bone miRNAs and suggests their involvement in osteochondrosis physiopathology.

Authors:  Clémence Desjardin; Anne Vaiman; Xavier Mata; Rachel Legendre; Johan Laubier; Sean P Kennedy; Denis Laloe; Eric Barrey; Claire Jacques; Edmond P Cribiu; Laurent Schibler
Journal:  BMC Genomics       Date:  2014-09-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.